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Introduction: Lipodystrophy is common in patients infected with human immunodeficiency virus receiving highly
active antiretroviral therapy, and presents with morphologic changes and metabolic alterations that are associated
with depressive behavior and reduced quality of life. We examined the effects of exercise training on
morphological changes, lipid profile and quality of life in a woman with human immunodeficiency virus presenting
with lipodystrophy.
Case presentation: A 31-year-old Latin-American Caucasian woman infected with human immunodeficiency virus
participated in a 12-week progressive resistance exercise training program with an aerobic component. Her weight,
height, skinfold thickness, body circumferences, femur and humerus diameter, blood lipid profile, maximal oxygen
uptake volume, exercise duration, strength and quality of life were assessed pre-exercise and post-exercise training.
After 12 weeks, she exhibited reductions in her total subcutaneous fat (18.5%), central subcutaneous fat (21.0%),
peripheral subcutaneous fat (10.7%), waist circumference (WC) (4.5%), triglycerides (9.9%), total cholesterol (12.0%)
and low-density lipoprotein cholesterol (8.6%). She had increased body mass (4.6%), body mass index (4.37%),
humerus and femur diameter (3.0% and 2.3%, respectively), high-density lipoprotein cholesterol (16.7%), maximal
oxygen uptake volume (33.3%), exercise duration (37.5%) and strength (65.5%). Quality of life measures improved
mainly for psychological and physical measures, independence and social relationships.
Conclusions: These findings suggest that supervised progressive resistance exercise training is a safe and effective
treatment for evolving morphologic and metabolic disorders in adults infected with HIV receiving highly active
antiretroviral therapy, and improves their quality of life.
Introduction
The use of highly active antiretroviral therapy (HAART)
reduces morbidity and mortality rates and improves the
wellbeing of patients who are human immunodeficiency
virus (HIV) seropositive [1]. However, the use of HAART
is associated with changes in body fat deposits and meta-
bolic alterations. The term ‘lipodystrophy’ is traditionally
used to describe various morphological changes related
to fat redistribution, for example, lipoatrophy (the loss of
fat) and lipohypertrophy (fat accumulation). Lipoatrophy
and lipohypertrophy may occur separately or in combina-
tion in one individual [2]. In some patients infected with
HIV, the changes are characterized by increased central
body fat accumulation, including visceral adipose tissue.
This can present as abdominal obesity or, more rarely, an
accumulation of fat in the dorsocervical region, called
‘buffalo hump’. Disturbances in body fat distribution may
be accompanied by metabolic disorders including glucose
intolerance, insulin resistance, hypertension and dyslipi-
demia [3]. Morphologic and metabolic disturbances
result in impaired body image and a risk of cardiovascu-
lar diseases and diabetes.
Disturbances in body fat distribution may also be
accompanied by lipoatrophy, which typically involves loss
of subcutaneous fat from the face, arms, legs and buttocks.
Although the combination of visceral adiposity and meta-
bolic disorders is not unique to the HIV population receiv-
ing HAART, its pathogenesis and clinical presentation in
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any medium, provided the original work is properly cited.these patients seem to be different from that of the general
population [4]. In individuals who are HIV seronegative,
regular physical activity is associated with favorable
changes in blood lipids, particularly an increase in plasma
high density lipoprotein (HDL) cholesterol, a reduction in
plasma triglycerides and the ratio between total cholesterol
and HDL cholesterol [5]. Based on this premise, the cur-
rent guidelines recommend physical activity as non-phar-
macological treatment for individuals who are HIV-
positive with dyslipidemia who are receiving HAART [6],
and exercise training reportedly minimizes depressive
symptoms in women infected with HIV [7]. There are few
studies examining the effects of aerobic and resistance
exercise training on lipodystrophy and quality of life in
adults infected with HIV, suggesting the need to test
further these interventions in people of all races who are
HIV-positive.
Case presentation
A 31-year-old Latin-American Caucasian woman
infected with HIV through a heterosexual relationship
with a partner received treatment at the Health Promo-
tion Centre (HPC) of Conselheiro Lafaiete, Brazil. She
had oral candidiasis and had started to develop depres-
sion. These were controlled with the use of ketoconazole
400 mg and fluoxetine 20 mg daily, respectively. She was
vaccinated against hepatitis B and started combined ther-
apy with lamivudine (3TC) 150 mg and zidovudine
(AZT) 300 mg plus nevirapine 200 mg twice daily when
her viral load was over 500,000 copies, her CD4+ level
was 33 cells/μL and CD8+ level was 287 cells/μL. This
regimen improved our patient’s health. Seven months
later, there was a reduction in viral load to 1084 copies,
an increase of CD4+ by 130 cells/μLa n dC D 8 +b y5 0 3
cells/μL. 3TC/AZT/NPV were started but replaced for
3TC/d4T/NPV due to anemia. With the new regimen,
the viral load became undetectable, with an increase of
CD4+ to 212 cells/μL and CD8+ to 762 cells/μL. She
continued the recommended regular medical visits
(Table 1).
During the sixth medical visit, our patient reported
concerns about a loss of muscle mass. She was clinically
diagnosed as having lipoatrophy of the upper and lower
limbs. She showed increased dissatisfaction with her
appearance during her next medical visit.
After another 10 months, our patient signed an
informed consent form to voluntarily participate in this
study after guided ethical information was provided. This
study was approved by the Ethics Committee in Human
Research of the Federal University of Viçosa-Minas
Gerais. All measurements were performed after a
24-hour abstention from strenuous exercise, and blood
samples were collected after a 12-hour fast. At baseline
a n da t1 2w e e k s ,a n t h r o p o m e t r i cm e a s u r e s ,m a x i m u m
oxygen uptake (VO2max), blood samples and quality of life
measures were assessed. Strength tests were performed at
baseline, six and 12 weeks.
The exercise program consisted of 12 weeks of super-
vised exercise (preceded by two weeks of adaptation)
performed three times per week on non-consecutive days
(Table 2). During the period of adaptation, aerobic train-
ing was performed on a treadmill with crescent intensity,
ranging from 50% to 60% of the heart rate reserve (HRR),
as determined by the maximal treadmill exercise test.
Resistance training, three sets of six to ten repetitions,
was performed at 60% of one maximum voluntary con-
traction (1-RM). All training sessions were performed at
the Centre for Research (accredited by the HPC), super-
vised by one of the authors of this study (ELM). The car-
diovascular exercise was performed on a treadmill with
crescent intensity, ranging from 50% to 80% of HRR. We
used the American College of Sports Medicine (ACSM)
metabolic equation for measurement of cardiorespiratory
fitness, using the “walking” equation, to estimate VO2max
for the modified Bruce protocol: VO2max(mL/kg/min) =
(speed(m/min) × 0.1+((grade(decimal) × speed(m/min) ×
1.8)+3.5. Heart rate was monitored during all sessions to
ensure that proper training intensity was maintained.
Three sets of eight to ten repetitions were performed at
80% of 1-RM according to the guidelines of the ACSM
[8]. Six resistance training exercises, targeting the large
muscle groups of the body, were performed in the follow-
ing order: seated leg press, chest press, leg curl, pulldown,
leg extension, seated rows.
Table 1 History of medical visits performed by the HPC
Medical visits Therapeutic regimen Viral load CD4+ CD8+ Presence of lipodystrophy
1 AZT/3TC/NVP >500,000 33 297 No
2 d4T/3TC/NVP 1084 130 503 No
3 d4T/3TC/NVP <50 212 762 No
4 d4T/3TC/NVP <50 319 1063 No
5 d4T/3TC/NVP <50 477 1253 No
6 d4T/3TC/NVP <50 663 1245 Yes
7 d4T/3TC/NVP <50 547 1322 Yes
8 d4T/3TC/NVP <50 675 1130 Yes
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tion, biochemical and immune characteristics are shown
in Table 3. For body fat assessment, we used the metho-
dology proposed by Florindo et al.[ 9 ] .P o s i t i v ec h a n g e s
were observed in her body composition at the end of the
intervention. The central subcutaneous fat and peripheral
subcutaneous fat showed a reduction of 18.5 mm and
3 mm, respectively. This result equated to a reduction of
22.8% in total subcutaneous fat. Body density was calcu-
lated using the equation of Jackson et al. [11] for women,
and this result was then used to calculate body fat per-
centage, using the equation of Siri [10]. Our patient’s
body fat percentage decreased 18.5% due to the loss of
2.1 kg of body fat. Her fat-free mass (FFM) increased by
4.9 kg. Both her femur and humerus diameters, measured
using a digital paquimeter, increased by 2 mm. Blood
samples were measured in a clinical laboratory. There
was a reduction in triglycerides (9.9%), total cholesterol
(12%), and low-density lipoprotein cholesterol (LDL)
(8.6%) and an increase in HDL cholesterol (16.7%). Lym-
phocytes and neutrophils increased by 97 and 55 cells/
mm
3, respectively. These results were associated with an
increase of 2.9% in total leukocytes.
Fitness characteristics indicate that her VO2max and
exercise duration increased by 8mL/kg/minute and three
minutes, respectively (Table 4). Her maximum dynamic
muscle strength increased for all six trained muscle
groups (range of increase 54.5% to 83.3%) (Table 4).
Quality of life measures were assessed using the World
Health Organization Quality of Life assessment instru-
ment in patients with HIV best available reference tech-
niques. These measures improved mainly for the
psychological domain, followed by the physical domain,
her level of independence, personal relationships and
environment (Figure 1).
Discussion
We have shown that a 12-week exercise program results
in weight gain and improved body composition changes
in a woman infected with HIV with lipodystrophy syn-
drome. Body composition, lipid profile, maximum oxygen
consumption, strength, and quality of life improved as
observed in previous studies [2,12]. Changes in body
composition were also similar to those seen in the case
study of a man infected with HIV reported by Roubenoff
et al.[ 1 3 ] .S e v e r a ls t u d i e si n v o l ving exercise training for
adults who are HIV-positive have also reported a reduc-
tion in body fat composition and increased FFM [2,7,12].
The reduction in the measurements of her chest and
waist, and increased diameter of her mid-arm, forearm,
thigh and calf could have been crucial to changing our
patient’s perception of her body image. Quality of life
measures in the physical and psychological domains
improved after exercise training, as reported by others
[14].
There were decreases in visceral and subcutaneous fat in
the central region of her body, which has been associated
with insulin resistance, dyslipidemia, hypercholesterolemia
and risk for cardiovascular disease. Although we have not
used methods of radiologic imaging, the intervention
resulted in WC reduction above the recommended cut-off
point for women (WC ≥ 80 cm) [15]. Consequently, her
lipid profile changed positively after exercise training with
a reduction in triglycerides, total cholesterol, LDL choles-
terol and an increase in HDL cholesterol.
Carr et al. [16] similarly reported that low body weight
before commencing HAART is associated with lactic
acidosis attributed to nucleoside transcriptase reverse
inhibitors; this provides a foundation for osteopenia in
men who are HIV-positive. Our results reinforce the
importance of exercise training on the maintenance of
bone mass at baseline levels.
Our findings can only be applied to this case, but sug-
gest that exercise training might be safe for treatment of
lipodystrophy-related body changes (mainly central adip-
osity) and improve the lipid profile without adverse
changes in immunologic outcomes. However, this is only
a case study and the exact contribution of each type of
exercise (resistance and aerobic training) needs to be
ascertained in further studies.
Her increased oxygen consumption and strength were
the most significant results. This can be explained by
both the increase in lean mass, of 4.9kg, and the fact that
after infection our patient was deprived of social contact
and participated more in regular physical exercise. Power
et al. [17] reported that lipodystrophy-related body
Table 2 Exercise intervention design
Weeks Sessions/week Session Aerobic Resistance training
0 3 1 20 minutes 60% to 70% HRR 6 to 8 reps 70% 1-RM
2 20 minutes 60% to 70% HRR 8 to 10 reps 70% 1-RM
3 20 minutes 60% to 70% HRR 8 to 10 reps 70% 1-RM
1 to 12 3 1 20 minutes 70% to 80% HRR 8 to 10 reps 80% 1-RM
2 20 minutes 70% to 80% HRR 8 to 10 reps 80% 1-RM
3 20 minutes 70% to 80% HRR 8 to 10 reps 80% 1-RM
reps: repetitions.
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ranging from bodily discomfort to low self-esteem and
depression, and this likely influenced our patient’s
increased participation in exercise training to gain psy-
chological comfort. Lipodystrophy-related morphological
changes result in individuals narrowing their social
world, and in some cases result in social isolation. Thus,
these body changes resulting in a ‘slim body’ in the HIV-
positive population are commonly associated with loss of
lean body mass. We did not measure oxygen consump-
tion directly, but instead used a prediction equation [18]
not previously validated in a population with HIV
infection.
Power et al. [17] reported that three years of HAART
negatively affected psychosocial wellbeing, mainly due to
changes in body image. Préau et al. [19] provided evi-
dence that the reduced quality of life in women is asso-
ciated with the accumulation of body fat. Our results
support these prior findings, and further suggest that a
reduction in body fat was directly related to the
improvements in their quality of life.
Conclusions
Regular exercise training improved physical fitness and
was effective and safe in mitigating changes associated
with lipodystrophy and dyslipidemia in a woman
infected with HIV. These preliminary results suggest
that supervised progressiver e s i s t a n c ee x e r c i s ei sa n
inexpensive and practical treatment for lipodystrophy
body changes and dyslipidemia, and improves quality of
life in adults infected with HIV.
Patient’s perspective
I think that exercise improved my health and it is very
important to maintain it. I noted that it greatly improved
my body; my paunch has decreased in size but I still want
more. I think the main change was the increase in my
weight and my legs.
Consent
Written informed consent was obtained from the patient
for publication of this case report and any accompany-
ing images. A copy of the written consent is available
for review by the Editor-in-Chief of this journal.
Table 3 Values determined at baseline and after







Body mass, kg 61.2 64 2.8 4.6
Body mass index, kg/
m
2
22.21 23.23 1.02 4.6
Circumferences, cm
Neck circumference 35 33.7 -1.3 -3.7
Chest circumference 93 91.5 -1.5 -1.6
Waist circumference 82 78.3 -3.7 -4.5
Mid-arm
circumference
27 29.4 2.4 8.9
Forearm
circumference
23.5 24.4 0.9 3.8
Thigh circumference 50 51.2 1.2 2.4
Calf circumference 33.5 34.2 0.7 2.1
Waist-to-hip ratio
(WHR)
0.91 0.87 -0.04 -4.3
Body composition
TSF, mm 116.0 94.5 -21.5 -18.5
CSF, mm 88 69.5 -18.5 -21.0
PSF, mm 28 25 -3 -10.7
Fat, % 24.1 19.7 -4.4 -18.3
Body fat, kg 14.7 12.6 -2.1 -12.5
FFM, kg 46.5 51.4 4.9 12.7
Femur, cm 8.4 8.6 0.2 2.4
Humerus, cm 6.4 6.6 0.2 3.1
Metabolic and immunological values
Triglycerides, mg/dL 142 128 -14 -9.9
Total cholesterol, mg/
dL
225 198 -27 -12.0
LDL cholesterol, mg/
dL
162 148 -14 -8.6
HDL cholesterol, mg/
dL
36 42 6 16.7
HbA1c 6.12 6.06 -0.06 -1.0
Fasting glucose, mg/
dL
88 90 2 2.3
Leukocytes, cells/m
3 6900 7100 200 2.9
Lymphocytes, cells/m
3 2463 2560 97 3.9
Neutrophils, cells/m
3 3760 3815 55 1.5
Basophils, cells/m
3 82.8 81.4 -1.4 -1.7
Monocytes, cells/m
3 448.5 455 6.5 1.4
Platelets, cells/m
3 279,000 278,600 -400 -0.1
CSF: subcutaneous fat; HbA1c: glycated fasting hemoglobin; PSF: peripheral
subcutaneous fat; TSF: total subcutaneous fat.








VO2max, mL/kg/min 24 33 8 33.3
exercise duration,
min
8 11 3 37.5
Strength measures,
kg
leg curl 8 14 6.0 75.0
pulldown 16 28 12.0 75.0
seated leg press 30 55 25.0 83.3
chest press 12 20 8.0 66.7
seated rows 22 34 12.0 54.5
leg extension 18 25 7.0 38.9
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